Companies

REGENXBIO Inc. (RGNX) SEC filings

CIK 0001590877 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)170.4 M90.2 M
Net income (USD)-280.3 M127.8 M-111.3 M
Diluted EPS (USD/shares)-3.76-6.02

Latest filings

FiledFormDescriptionPeriod
2026-10-168-K8-K items 5.022026-10-14
2026-10-13SCHEDULE 13GSCHEDULE 13G
2026-09-238-K8-K items 1.012026-09-23
2026-09-034PRIMARY DOCUMENT2026-09-01
2026-09-034PRIMARY DOCUMENT2026-09-01
2026-08-274PRIMARY DOCUMENT2026-08-25
2026-08-273PRIMARY DOCUMENT2026-08-25
2026-08-258-K8-K items 5.02,9.012026-08-25
2026-08-248-K8-K items 7.01,8.01,9.012026-08-24
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-08-044PRIMARY DOCUMENT2026-08-01
2026-08-044PRIMARY DOCUMENT2026-08-01
2026-07-208-K8-K items 8.01,9.012026-07-16
2026-07-17424B5424B5
2026-07-17FWPFWP
2026-07-16424B5424B5
2026-07-064PRIMARY DOCUMENT2025-12-31
2026-07-064PRIMARY DOCUMENT2026-07-02
2026-07-06SC TO-I/ASC TO-I/A
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-01144144
2026-07-01SC TO-I/ASC TO-I/A
2026-06-298-K8-K items 8.01,9.012026-06-23
2026-06-04SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 400, 8-K 117, SC 13G/A 48, 10-Q 33, 3 26, SC 13G 16, 144 15, 424B5 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=RGNX (0.002 USD), /gw/filings/filings?ticker=RGNX&form=8-K, /gw/filings/facts?ticker=RGNX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange